Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations-Reference-Cited by-同舟云学术

Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations

Published:2022-03-22 Issue:8 Volume:11 Page:966-975
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Incledon Bev¹,Incledon Chantal¹,Gomeni Roberto²,Uchida Cassandra L.³,Morris Amy⁴,Perry Kim⁵,Kapuscinski Jill¹

Affiliation:

1. Ironshore Pharmaceuticals & Development, Inc. Camana Bay Grand Cayman Cayman Islands

2. PharmacoMetrica France La Fouillade France

3. Highland Therapeutics Inc. Toronto Ontario Canada

4. IND 2 Results LLC Atlanta Georgia USA

5. Innovative Analytics Kalamazoo Michigan USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1089

Reference19 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers

3. Functional Impairment in Youth With ADHD

4. The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment

5. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are all ADHD medications created equal? Exploring the differences that enable evening dosing;Postgraduate Medicine;2024-06-26

2. Pharmacokinetics of Long-Acting Methylphenidate: Formulation Differences, Bioequivalence, Interchangeability;European Journal of Drug Metabolism and Pharmacokinetics;2023-12-21

3. Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program;Clinical Therapeutics;2023-12

4. A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule;CPT: Pharmacometrics & Systems Pharmacology;2023-10-31

5. Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management;Expert Review of Clinical Pharmacology;2023-08-22